Shock: all 921 studies

Page 5 of 10. Open to participants first (171), then studies with results posted, then the rest; newest registration first within each.

• Cytokine Adsorption in Severe, Refractory Septic ShockCompletedNCT04910893Not applicable
• Cytokine Hemoadsorption in ECMO PatientsCompletedNCT04901338
• Efferon LPS Hemoperfusion for Treatment of Patients With Septic ShockCompletedNCT04884854
• Incorporating Supersaturated Oxygen in ShockWithdrawnNCT04876040Not applicable
• Effects of Norepinephrine and Volume Expansion in Capillary Refill Time in Septic ShockStatus unknownNCT04870892
• Scoring Model for Predicting Outcome in Patients With Cardiogenic ShockStatus unknownNCT04850248
• Study of the Role of Hemostasis in Perioperative AnaphylaxisStatus unknownNCT04825158
• A 48 Subject Study Using Non-invasive Multi-Technology Measurements for Early Detection of Ongoing HemorrhageTerminatedNCT04814810
• Fluid Balance Neutralization During CRRT (Continuous Renal Replacement Therapy)CompletedNCT04801784Not applicable
• High-dose Intravenous Vitamin C in Patients With Septic ShockStatus unknownNCT04796636Phase 1
• Modulation of Endothelial Dysfonction Using Vitamin C in Septic Shock PatientsStatus unknownNCT04778605
• Extracorporeal Shock Wave Versus Local Corticosteroid Injection for Carpal Tunnel SyndromeCompletedNCT04767724Phase 4
• Prehospital Management of Hypotensive Trauma in HEMSCompletedNCT04760977
• Fluid Resuscitation in Septic Shock Patients With BMI ElevationTerminatedNCT04759989Not applicable
• SHARED Study (Saguenay Hospitals Anaphylaxis Rule for Early Discharge)TerminatedNCT04755881
• Early Administration of Vitamin C in Patients With Sepsis or Septic Shock in Emergency DepartmentsCompletedNCT04747795Phase 3
• Extracorporal Cytokin Removal in Septic Shock: a Prospective, Randomized, Multicenter Clinical TrialSuspendedNCT04742764Phase 3
• LEVOSIMENDAN to Facilitate Weaning From ECMO in Severe Cardiogenic Shock PatientsCompletedNCT04728932Phase 3
• Septic Shock Management Guided by Ultrasound: SEPTICUS TrialStatus unknownNCT04728529Not applicable
• Evaluation of Plasma Angiotensin II and Angiotensin II Receptor Levels in Patients With Sepsis and Septic Shock: a Prospective Observational Study.Status unknownNCT04716842
• Validation of Uncalibrated Cardiac Output Measurement With LiDCOrapid in the Resuscitation of Critically Ill Patients With Septic Shock: A Prospective Cross-sectional Study.CompletedNCT04705493
• Capillary Refill Time Response to a Rapid Fluid Challenge in Septic Shock PatientsStatus unknownNCT04693923Not applicable
• Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue PatientsCompletedNCT04673422Phase 2/3
• Effects of Hydrocortison Treatment on Angiotensin II and Angiotensin II Receptors in Patients With Septic ShockCompletedNCT04647552
• Treatment With the Ketone Body 3-hydroxybutyrate in Patients With Cardiogenic ShockCompletedNCT04642768Not applicable
• the Effect of Oral Vasopressors for Liberation From IV Vasopressors in Spinal ShockStatus unknownNCT04586790Phase 2
• G- Forces On Retrieved ChildrEn Pilot StudyCompletedNCT04586374
• Muscle Ultrasound Study in Shock PatientsCompletedNCT04550143
• Prediction of Arterial Lactate and Blood Gas Values Through the Analysis of Central Venous BloodCompletedNCT04538339
• Sonographic QUantification of Venous Circulation In the Preterm BrainCompletedNCT04535375Not applicable
• Evaluation of Efficacy of the Prototype RPC (Rapid Pulse Confirmation) Device in Detecting Return of Pulsatile Flow in Patients Preparing to Separate From CPB (Cardiopulmonary Bypass)CompletedNCT04526249
• Whether a Minimal Volume Could Predict Fluid Responsiveness Using Thermodilution by PAC in Septic Shock PatientsStatus unknownNCT04515511Not applicable
• Triple Therapy in Septic Shock PatientsCompletedNCT04508946Phase 3
• Acetated Ringer's Solution Versus Saline in Patients With Septic ShockStatus unknownNCT04507672Not applicable
• The Accuracy of Pediatric Air Test as a Non-invasive Atelectasis Diagnostic ToolCompletedNCT04506203Not applicable
• Prehospital Norepinephrine and Early Mortality in Traumatic ShockCompletedNCT04497155
• Fludrocortisone Dose Response Relationship in Septic Shock - FluDReSSCompletedNCT04494789Phase 2
• Evaluation of the Role of Hydrocortisone Either Alone or Combined With Fludrocortisone in the Outcome of Septic Shock in AdultsCompletedNCT04492280Phase 4
• Shock Index, Modified Shock Index and Age-related Shock Index for Predicting Post-spinal Hypotension in Elderly PatientsStatus unknownNCT04483765
• Volumetric Analysis of Alveolar Ridge Contour Using Sub-epithelial Connective Tissue GraftCompletedNCT04482127Not applicable
• The Application of Point-of-care Ultrasonography in Differential Diagnosis of Shock in Emergency and Critical CareCompletedNCT04478045
• Health Literacy Among Caregivers of Children With IgE-mediated Allergy With Risk of AnaphylaxisStatus unknownNCT04475003
• Follow-up of Critical COVID-19 PatientsStatus unknownNCT04474249
• Carotid Doppler and EEOT for Fluid Responsiveness PredictionCompletedNCT04470856Not applicable
• Prospective Register on the Etiologies of Cardiogenic Shock and Their Prognosis at One Year.Status unknownNCT04467294
• As an Early Indicator Biomarker of Prognosis and Mortality in Children With Sepsis and Septic Shock: suPARCompletedNCT04459572Not applicable
• Bicarbonated Ringer's Solution Versus Lactated Ringer's Solution in Patients With Septic ShockStatus unknownNCT04449757Not applicable
• Methylene Blue in Early Septic ShockCompletedNCT04446871Phase 2/3
• Cerebral Compliance Impairment in COVID-19CompletedNCT04429477
• Ratio of ''Central Venous-to-Arterial Co2 Gap'' to ''Arterial-to-Central Venous O2 Content Gap'' in Septic ShockStatus unknownNCT04425161
• Hemodynamic Optimisation Guided With Transcranial Doppler in Septic ShockStatus unknownNCT04398069Not applicable
• Fluid REsponsiveness and Arterial ELASTANCE in Patients With Septic Shock or After Aortic SurgeryStatus unknownNCT04388267
• Study on Early Intra-aortic Balloon Pump Placement in Acute Decompensated Heart Failure Complicated by Cardiogenic ShockTerminatedNCT04369573Phase 4
• European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMOStatus unknownNCT04366921
• Low-chlorine Vs High-chlorine Crystalloids in Septic Shock AdultsStatus unknownNCT04365010Phase 4
• Assessment of Agreement Between Two Measurement Methods of Left Ventricular Outflow Tract (LVOT) Velocity Time Integral (VTI)CompletedNCT04360304Not applicable
• The RIsk Stratification in COVID-19 Patients in the ICU RegistryActive, not recruitingNCT04357275
• Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19No longer availableNCT04352985
• Hemodynamic Characteristics of Patients With SARS-CoV-2CompletedNCT04337983
• The Safety and Efficacy of Istaroxime for Pre-Cardiogenic ShockCompletedNCT04325035Phase 2
• Levosimendan for Veno-arterial ECMO WeaningCompletedNCT04323709
• Evaluation of Sepsis-induced Immunosuppression Base on QuantiFERON Monitor® in Septic ShockWithdrawnNCT04320394Not applicable
• Extracorporeal Shock Wave Therapy on Wrist and Hand Functions in Spastic Chronic Stroke PatientsCompletedNCT04312581Not applicable
• Renin as a Biomarker of Haemodynamic NormalisationCompletedNCT04303455
• Norepinephrine / Vasopressin Combination for Resuscitation in Septic ShockCompletedNCT04302584Not applicable
• Methylene Blue and Microcirculation in Septic ShockStatus unknownNCT04295993Phase 3
• Brain Ultrasound With Contrast Microbubbles Injection in Shock StatusStatus unknownNCT04290767Not applicable
• Characterisation of Large Airway Collapse During Exercise (LACE)Status unknownNCT04264052
• Improvement of Cerebrovascular Autoregulation in Patients With Septic Shock Due to Cytokine EliminationStatus unknownNCT04259567Not applicable
• VBI-S for the Treatment of Hypotension in Hypovolemic Septic Shock PatientsActive, not recruitingNCT04257136Phase 2
• The Effects of Oxiris on Systemic Inflammation and Endothelial dysFunctionStatus unknownNCT04257006Not applicable
• Microcirculatory Effects of Methylene BlueCompletedNCT04250389
• The Effect of Lateral Tilt on Ventilation Distribution in Lungs Assessed by Electrical Impedance TomographyCompletedNCT04235231Not applicable
• Therapeutic Plasmaexchange in Early Septic ShockCompletedNCT04231994Phase 2
• Extracorporeal Cytokine Removal in Patients With Septic Shock in an Adult Intensive Care UnitStatus unknownNCT04231695
• Study of the Role of Interferon αon the Endothelial Dysfunction During Septic ShockStatus unknownNCT04204694
• Clinical Validation of Algorithms for Mean Systemic Filling Pressure and Automated Cardiac OutputCompletedNCT04202432
• Efficacy and Safety of Therapy With IgM-enriched Immunoglobulin With a Personalized Dose vs Standard Dose in Patients With Septic Shock.Status unknownNCT04182737Phase 3
• Direct Assessment of Microcirculation In Shock (DAMIS)CompletedNCT04173221Not applicable
• Effect of Fluid Deresuscitation With Central Venous Pressure Target 0-4 mmHg in Septic Shock PatientsCompletedNCT04156451Not applicable
• The Current Status and Clinical Outcomes of Patients With Cardiogenic Shock IIStatus unknownNCT04143893
• Global Longitudinal Strain Assessment in Cardiogenic Shock During SepsisStatus unknownNCT04141410
• VItamin C in Thermal injuRY: The VICToRY TrialSuspendedNCT04138394Phase 3
• The Effect of Increasing the Mean Arterial Pressure on the Microcirculation and the Prognosis of Patients With Septic ShockStatus unknownNCT04136080Not applicable
• EMS Prehospital Blood Culture Collection and Antibiotic Administration: A Two-Phase Pilot Project to Reduce Mortality in Patients With Severe Sepsis and Septic ShockTerminatedNCT04134624Not applicable
• Steroids, Thiamine and Ascorbic Acid in Septic ShockStatus unknownNCT04134403Phase 3
• Adjuvant Use of Neostigmine in Sepsis and Septic Shock.CompletedNCT04130230Phase 2
• Truth or Dare; Artificial Blastocoel Collapse Using Laser Before Blastocyst's Vitrification Versus Non-laser UsageTerminatedNCT04124809Not applicable
• Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in Patients With Septic Shock Suffering From Organ FailureCompletedNCT04123444Phase 2/3
• Fluid Overload Quantification in Septic ShockCompletedNCT04114162
• Pilot Study on the Use of Hydrocortisone, Vitamin c and Tiamine in Patient With Sepsis and Septic ShockCompletedNCT04111822Phase 3
• Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm NeonateStatus unknownNCT04110418Phase 2
• PLatelets Acetyl-CoA Carboxylase Phosphorylation State in SEPtic ShockCompletedNCT04107402Not applicable
• Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in SepsisCompletedNCT04102371Phase 3
• VOLume and Vasopressor Therapy in Patients With Hemodynamic instAbilityCompletedNCT04089098
• Methylene Blue as a Third-line Vasopressor in Septic ShockStatus unknownNCT04089072Phase 2
• Pro-inflammatory Role of Blood Platelets in Critically Ill Patients With Septic Shock.CompletedNCT04080453
• Postoperative Respiratory AbnormalitiesStatus unknownNCT04079829
• PMZ-2010 (Centhaquine) as a Resuscitative Agent for Hypovolemic ShockCompletedNCT04056065Phase 2
• Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic ShockActive, not recruitingNCT04055909Phase 2

← Shock overview